Our mission is to unleash the power of personalized medicine.
TheraCea develops clinical diagnostic tools for the faster and more accurate detection of cancer and neurological disorders, as well as for best-in-class therapy matching and rapid assessment of therapy efficacy.
TheraCea has partnered with the National Science Foundation and National Institutes of Health to move the technology from the chemistry bench to clinics.
the gift of time for Patients and Doctors
TheraCea's technology provides accurate therapy matching and treatment efficacy assessments to patients and their oncologists or neurologists in days rather than months (the current standard of care), improving a patient's prognosis by offering the time to employ additional therapies if needed.
Tools for acceleration of clinical trials
TheraCea's diagnostic tools increase the probability of matching high-potential therapies meant to target specific aspects of cancers or neurological disorders to the patients who will potentially benefit the most. Furthermore, the tools allow fast efficacy assessments for pipeline immunotherapy treatments.
TheraCea creates radiotracer and detection technology for the development of and application in cancer and neurological therapies.